Evidence map›Paper›PMID 29261182›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2018

Biallelic and monoallelic ESR2 variants associated with 46,XY disorders of sex development.

Dorien Baetens, Tülay Güran, Berenice B Mendonca, Nathalia L Gomes, Lode De Cauwer, Frank Peelman, Hannah Verdin, Marnik Vuylsteke, Malaïka Van der Linden, ESR2 STUDY GROUP and 11 more

Open access · hybridAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Is sex still binary?Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Haploinsufficiency of PRR12 causes a spectrum of neurodevelopmental, eye, and multisystem abnormalities.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  11. Estrogen Signaling in Bone.Applied sciences (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Long-Term Follow-Up and Treatment of a Female With Complete Estrogen Insensitivity.The Journal of clinical endocrinology and metabolism · 2020
    Article
  14. Review
  15. Male Hypogonadism and Disorders of Sex Development.Frontiers in endocrinology · 2020
    Review
  16. Article
  17. Impact of estrogens in males and androgens in females.The Journal of clinical investigation · 2019
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 4 countries.

Dorien BaetensCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Tülay GüranZeynep Kamil Maternity and Children's Diseases Training and Research Hospital, Division of Pediatric Endocrinology and Diabetes, Istanbul, Turkey.
Berenice B MendoncaDisciplina de Endocrinologia, Laboratorio de Hormonios e Genetica Molecular LIM/42, Unidade de Adrenal, Disc. de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Nathalia L GomesDisciplina de Endocrinologia, Laboratorio de Hormonios e Genetica Molecular LIM/42, Unidade de Adrenal, Disc. de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Lode De CauwerReceptor Research Laboratories, Nuclear Receptor Lab, Department of Medical Protein Research, VIB, Ghent, Belgium.
Frank PeelmanReceptor Research Laboratories, Nuclear Receptor Lab, Department of Medical Protein Research, VIB, Ghent, Belgium.
Hannah VerdinCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Marnik VuylstekeGNOMIXX ltd, Statistics for Genomics, Melle, Belgium.
Malaïka Van der LindenDepartment of Medical and Forensic Pathology, Ghent University and Ghent University Hospital, Ghent, Belgium.
ESR2 STUDY GROUP
Zeynep Atay
Abdullah Bereket
Ronald R de Krijger
Katleen de Preter
Sorahia Domenice
Serap Turan
Hans StoopDepartment of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Leendert H LooijengaDepartment of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Karolien De BosscherReceptor Research Laboratories, Nuclear Receptor Lab, Department of Medical Protein Research, VIB, Ghent, Belgium.
Martine CoolsDepartment of Pediatrics, Division of Pediatric Endocrinology, Ghent University and Ghent University Hospital, Ghent, Belgium.
Elfride De BaereCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium. Elfride.DeBaere@ugent.be.
Ghent University Hospital · BEGhent University · BEErasmus MC · NLHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRZeynep Kamil Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDisorders or differences of sex development (DSDs) are rare congenital conditions characterized by atypical sex development. Despite advances in genomic technologies, the molecular cause remains unknown in 50% of cases.

methodsHomozygosity mapping and whole-exome sequencing revealed an ESR2 variant in an individual with syndromic 46,XY DSD. Additional cases with 46,XY DSD underwent whole-exome sequencing and targeted next-generation sequencing of ESR2. Functional characterization of the identified variants included luciferase assays and protein structure analysis. Gonadal ESR2 expression was assessed in human embryonic data sets and immunostaining of estrogen receptor-β (ER-β) was performed in an 8-week-old human male embryo.

resultsWe identified a homozygous ESR2 variant, c.541_543del p.(Asn181del), located in the highly conserved DNA-binding domain of ER-β, in an individual with syndromic 46,XY DSD. Two additional heterozygous missense variants, c.251G>T p.(Gly84Val) and c.1277T>G p.(Leu426Arg), located in the N-terminus and the ligand-binding domain of ER-β, were found in unrelated, nonsyndromic 46,XY DSD cases. Significantly increased transcriptional activation and an impact on protein conformation were shown for the p.(Asn181del) and p.(Leu426Arg) variants. Testicular ESR2 expression was previously documented and ER-β immunostaining was positive in the developing intestine and eyes.

conclusionOur study supports a role for ESR2 as a novel candidate gene for 46,XY DSD.

Indexed as

AdolescentAllelesAmino Acid SubstitutionChildChromosome MappingDisorder of Sex Development, 46,XYEstrogen Receptor betaExome SequencingFemaleGene FrequencyHigh-Throughput Nucleotide SequencingHumansMaleMutationProtein ConformationStructure-Activity RelationshipESR2 protein, humanEstrogen Receptor beta

Identifiers

PMID29261182
OpenAlexW2765802148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.